about
Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapyAnalysis of the paired TCR α- and β-chains of single human T cellsAn Analysis of Trafficking Receptors Shows that CD44 and P-Selectin Glycoprotein Ligand-1 Collectively Control the Migration of Activated Human T-Cells.Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabAn epidemiological study on trigger factors and quality of life in psoriatic patientsMisbehaving macrophages in the pathogenesis of psoriasis.Use of Kv1.3 blockers for inflammatory skin conditions.Efalizumab: continuous therapy for chronic psoriasis.Family history of autoimmune disease in patients with Aicardi-Goutières syndrome.Biologic therapeutics in the treatment of psoriasis. Part 1: review.Targeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies.Emerging treatments in the management of psoriasis: biological targeting with ustekinumab.Epigenetics and psoriasis.B cells participate in tolerance and autoimmunity through cytokine production.Gene expression profile of dermal mesenchymal stem cells from patients with psoriasis.RNase 7 downregulates TH2 cytokine production by activated human T cells.Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient CasesStructure-activity relationship exploration of Kv1.3 blockers based on diphenoxylate.Biological markers in the etiology of psoriasis: Targeted treatment options.Malabsorption in psoriatic patients: cause or consequence?Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data.Autologous Adipose-Derived Mesenchymal Stromal Cells for the Treatment of Psoriasis Vulgaris and Psoriatic Arthritis: A Case Report.Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases.Pathogenesis of psoriasis and current challenges.The safety and efficacy of high-dose alefacept compared with a loading dose of alefacept in patients with chronic plaque psoriasis.Expression of Notch receptor and its target gene Hes-1 in bone marrow CD34+ cells from patients with psoriasis.Safety and Efficacy of a Milk-Derived Extract in the Treatment of Plaque Psoriasis: An Open-Label StudyEfalizumab in the Treatment of PsoriasisAdalimumab for the treatment of severe psoriasis and psoriatic arthritis
P2860
Q26827714-63903F2E-DD24-4A31-8A76-B3D3FCF7F569Q28729281-EFB0419C-4ECF-486E-B443-A75E147AA357Q29994863-5D06B6D6-4189-4CB6-B884-4D3B83A29CD4Q33573621-B24EB54F-2389-4B2C-AD5F-10498AFC1B8BQ34035874-A29EFE0F-94A5-405D-8428-6135448659A6Q34872805-9D8491D6-0C3D-4C1F-939A-A1ADFBD6EEE7Q35915882-E8CA831B-323E-4EE5-8F37-2B7A684E7AB5Q36099478-7BF34595-9ED7-40F8-B252-52BF44E2C2CCQ36430164-8B4C4EF2-5AF2-41B1-8919-B3556FA1F32CQ36826201-330A68E0-3EE0-41EE-AAD2-86FC94949086Q37342952-0BCC7B40-79FF-4D31-BC33-009B4E213134Q37857668-537FCC9C-EE5D-4612-858A-5ACA8ABBFDC8Q37933446-DF1D3991-E3D7-4A5D-A996-8109C982BBC7Q38163603-12A8DCB3-E769-4D56-A82C-996AD87D75A0Q38308592-AE82A833-DB15-4F83-BD2D-472F5550F23AQ38853990-F6AFFDE9-A897-4CDB-BDF4-1A83A61AAB6CQ39003398-7C486E83-EA6F-4F66-A26A-B46AC80EF237Q41048502-106ACF84-E4BA-4C00-8C27-004CA940ABA5Q43078162-ADAAA299-BD8D-4BFA-A596-F9780947FC2FQ44937717-000BA1CD-26E6-44A9-8785-258516E3650CQ45774045-8CE29066-9FDA-40B5-83E0-F3F0D8CF40E9Q46532647-1C5FE0A6-A3FB-4866-88FE-6A125C2E0CE1Q46574517-E73D6E96-0E37-4D74-8B66-DB4812066013Q48302992-54CAAEBF-C366-445A-AC35-9EAFF8F1179AQ48488976-DCEBD545-B994-45B0-93F8-37D57D9A0CE7Q51444131-B76B0F01-485C-447C-AA4F-EE610DE0BBE1Q51992147-3A4B1D49-6585-40E4-9099-2CCFB88E4CB8Q53312205-0EA5210C-A593-4D5C-8313-89D6DD2F16FDQ53430510-9FC4FDB0-E651-4083-A50E-C1848AFCE1CEQ54289139-DDEEB547-A9E0-4422-8024-6BF47CEA7FD0Q56906257-A6AF321F-5718-4FF3-93FA-737CBF014290Q58404187-C4B17ADA-96F1-46CC-9C60-C4DD3D3B15F5Q58434950-ADAFE61B-4F42-4AB4-BC60-0E715B5C83D9
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The role of T cells in psoriasis.
@ast
The role of T cells in psoriasis.
@en
type
label
The role of T cells in psoriasis.
@ast
The role of T cells in psoriasis.
@en
prefLabel
The role of T cells in psoriasis.
@ast
The role of T cells in psoriasis.
@en
P2860
P1476
The role of T cells in psoriasis.
@en
P2093
P2860
P304
P356
10.1046/J.1468-3083.2003.00720.X
P577
2003-05-01T00:00:00Z